Paul Nankivell

Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial

Hisham Mehanna, Max Robinson, A. Hartley et al. · The Lancet · 2018 · 988 citations · Full text

Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study

James Glasbey, Adesoji Ademuyiwa, Adewale Adisa et al. · The Lancet Oncology · 2021 · 280 citations · Full text

Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis

Hisham Mehanna, Miren Taberna, Christian von Buchwald et al. · The Lancet Oncology · 2023 · 250 citations · Full text

Medicine, Oropharyngeal Cancer, Pathology +9

Safety and 30-day outcomes of tracheostomy for COVID-19: a prospective observational cohort study

Omar Breik, Paul Nankivell, Neil Sharma et al. · British Journal of Anaesthesia · 2020 · 123 citations · Full text

Medicine, Covid-19 Pandemic, Patient Safety +9

The binary oral dysplasia grading system: validity testing and suggested improvement

Paul Nankivell, Hazel Williams, Paul Matthews et al. · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · 2012 · 107 citations

Medicine, Oral Cavity, Oral Hygiene +6